Long-term Efficacy and Safety of HMS5552 in T2DM Subjects
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 463 participants.
Also called NCT03173391
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 463 participants
- Registry
-
NCT03173391
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03173391. Randomized; quadruple masking; primary purpose treatment. Start 2017-07-18 (actual); primary completion 2020-11-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Long-term Efficacy and Safety of HMS5552 in T2DM Subjects
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- HMS5552
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hua Medicine Limited
- Collaborator
- Tigermed Consulting Co., Ltd
Record details
- Record id
cardio:ct-nct03173391- Content hash
aae864f0f7a0b19f1bf757f0dc4e7a800fb95f4b2ce8c2ce9234e03bf208a165